QIAGEN N.V.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 24.0
- Dividend yield
- 0.54%
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2024 Ended Dec 31, 2024 | Apr 9, 2025 | During market hours | $483.00M | – | $0.55 |
Company guidance
Outlook given with results on Apr 8, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| adjusted diluted EPSnon-GAAP | Full-year 2025 | $2.35 | New |
| adjusted operating income marginnon-GAAP | Full-year 2025 | 30% | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Qiagen filed with the SEC
QIAGEN appoints Jonathan M. Pratt as Chief Executive Officer
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended June 30, 2026
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
2026 Annual General Meeting Proxy Statement QIAGEN N.V. Exhibit 99.2
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended March 31, 2026
EX-99.1 to Form 6-K
QIAGEN reports full results for Q1 2026
EX-99.1 to Form 6-K
QIAGEN reports preliminary Q1 2026 results: achieves
EX-99.1 to Form 6-K
QIAGEN exceeds Q4 2025 outlook driven by growth pillars
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended September 30, 2025
EX-99.1 to Form 6-K
Ad hoc Announcement according to Art. 17 Market Abuse Regulation
EX-99.3 to Form 6-K
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended June 30, 2025
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended March 31, 2025
EX-99.1 to Form 6-K
QIAGEN delivers solid Q4 2024 growth ahead of outlook
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended September 30, 2024
EX-99.1 to Form 6-K
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases
EX-99.1 to Form 6-K
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
EX-99.1 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended June 30, 2024
EX-99.1 to Form 6-K
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
EX-99.1 to Form 6-K
NOTICE OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
c/o Equiniti Trust Company, LLC
EX-99.3 to Form 6-K
QIAGEN announces 2028 strategy for solid profitable growth
EX-99.1 to Form 6-K
COMMITTED TO SOLID PROFITABLE GROWTH Capital Markets Day June 17, 2024
EX-99.2 to Form 6-K
U.S. GAAP Quarterly Report for the Period Ended March 31, 2024
EX-99.1 to Form 6-K